Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.26% | -20.79% | -0.41% | 32.10% | 26.80% |
| Total Depreciation and Amortization | 13.01% | 15.85% | 21.36% | 30.24% | 33.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 94.34% | 63.99% | 40.30% | -12.66% | 1.81% |
| Change in Net Operating Assets | -227.69% | -581.44% | -10.70% | -14.65% | 62.50% |
| Cash from Operations | 0.36% | -23.33% | 15.35% | 18.66% | 56.93% |
| Capital Expenditure | -15.87% | -0.07% | 16.93% | 36.93% | 43.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | 84.48% | 84.48% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -410.88% | -383.55% | -102.14% | -101.77% | -88.93% |
| Cash from Investing | -96.45% | -71.56% | 88.97% | 34.60% | 75.72% |
| Total Debt Issued | -- | -- | -- | 73.83% | -- |
| Total Debt Repaid | -712.00% | -212.31% | -34.62% | -19.87% | 79.34% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -52.66% | 85.07% | -273.60% | 14.29% | 50.58% |
| Cash from Financing | -20.91% | 55.83% | 88.26% | 93.07% | -8.10% |
| Foreign Exchange rate Adjustments | 581.55% | 250.52% | -54.21% | 527.88% | -28.75% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.53% | -52.19% | 467.52% | 219.89% | 183.56% |